Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage

This cross-sectional study examines the use of telemedicine for buprenorphine inductions among individuals with commercial insurance or Medicare Advantage during the temporary repeal of the Ryan Haight Act requirement of in-person evaluation before prescribing buprenorphine during to the COVID-19 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Barsky, Benjamin A., Busch, Alisa B., Patel, Sadiq Y., Mehrotra, Ateev, Huskamp, Haiden A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739765/
https://www.ncbi.nlm.nih.gov/pubmed/34989798
http://dx.doi.org/10.1001/jamanetworkopen.2021.42531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739765/
https://www.ncbi.nlm.nih.gov/pubmed/34989798
http://dx.doi.org/10.1001/jamanetworkopen.2021.42531

Ejemplares similares